These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 34672343

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
    Zhang JL, Wu T, Chen GW, Wang PY, Jiang Y, Tang JQ, Wu YC, Pan YS, Liu YC, Wan YL, Wang X.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May 25; 23(5):472-479. PubMed ID: 32842427
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Outcomes of urinary diversion after surgery for locally advanced or locally recurrent rectal cancer with complete cystectomy; ileal and colon conduit.
    Hagemans JAW, Voogt ELK, Rothbarth J, Nieuwenhuijzen GAP, Kirkels WJ, Boormans JL, Koldewijn EL, Richardson R, Verhoef C, Rutten HJT, Burger JWA.
    Eur J Surg Oncol; 2020 Jun 25; 46(6):1160-1166. PubMed ID: 32122756
    [Abstract] [Full Text] [Related]

  • 6. A 10-year experience of total pelvic exenteration for primary advanced and locally recurrent rectal cancer based on a prospective database.
    Nielsen MB, Rasmussen PC, Lindegaard JC, Laurberg S.
    Colorectal Dis; 2012 Sep 25; 14(9):1076-83. PubMed ID: 22107085
    [Abstract] [Full Text] [Related]

  • 7. Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer.
    PelvEx Collaborative.
    Br J Surg; 2018 May 25; 105(6):650-657. PubMed ID: 29529336
    [Abstract] [Full Text] [Related]

  • 8. Contemporary results from the PelvEx collaborative: improvements in surgical outcomes for locally advanced and recurrent rectal cancer.
    PelvEx Collaborative.
    Colorectal Dis; 2024 May 25; 26(5):926-931. PubMed ID: 38566456
    [Abstract] [Full Text] [Related]

  • 9. A systematic review examining quality of life following pelvic exenteration for locally advanced and recurrent rectal cancer.
    Rausa E, Kelly ME, Bonavina L, O'Connell PR, Winter DC.
    Colorectal Dis; 2017 May 25; 19(5):430-436. PubMed ID: 28267255
    [Abstract] [Full Text] [Related]

  • 10. Pathological determinants of outcome following resection of locally advanced or locally recurrent rectal cancer.
    Gould LE, Pring ET, Moorghen M, Burns EM, Antoniou A, Steele CW, Roxburgh CS, Jenkins JT.
    Eur J Surg Oncol; 2023 Nov 25; 49(11):106971. PubMed ID: 37442715
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Population-based study of surgical treatment with and without tumour resection in patients with locally recurrent rectal cancer.
    Westberg K, Palmer G, Hjern F, Holm T, Martling A.
    Br J Surg; 2019 May 25; 106(6):790-798. PubMed ID: 30776087
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Total Pelvic Exenteration for Locally Advanced and Recurrent Rectal Cancer: Urological Outcomes and Adverse Events.
    Khan O, Patsouras D, Ravindraanandan M, Abrar MM, Schizas A, George M, Malde S, Thurairaja R, Khan MS, Sahai A.
    Eur Urol Focus; 2021 May 25; 7(3):638-643. PubMed ID: 32622667
    [Abstract] [Full Text] [Related]

  • 16. Bladder preservation or complete cystectomy during pelvic exenteration of patients with locally advanced or recurrent rectal cancer, what should we do?
    Palma CA, van Kessel CS, Solomon MJ, Leslie S, Jeffery N, Lee PJ, Austin KKS.
    Eur J Surg Oncol; 2023 Jul 25; 49(7):1250-1257. PubMed ID: 36658054
    [Abstract] [Full Text] [Related]

  • 17. [Clinical study of using basement membrane biological products in pelvic floor reconstruction during pelvic exenteration].
    Chen GL, Wang YL, Zhang X, Tao Y, Sun YH, Chen JN, Wang SQ, Su N, Wang ZG, Zhang J.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Mar 25; 26(3):268-276. PubMed ID: 36925127
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Minimum radial margin in pelvic exenteration for locally advanced or recurrent rectal cancer.
    Aiba T, Uehara K, Tsuyuki Y, Ogura A, Murata Y, Mizuno T, Yamaguchi J, Kokuryo T, Yokoyama Y, Ebata T.
    Eur J Surg Oncol; 2022 Dec 25; 48(12):2502-2508. PubMed ID: 35768314
    [Abstract] [Full Text] [Related]

  • 20. Total pelvic exenteration for primary and recurrent malignancies.
    Ferenschild FT, Vermaas M, Verhoef C, Ansink AC, Kirkels WJ, Eggermont AM, de Wilt JH.
    World J Surg; 2009 Jul 25; 33(7):1502-8. PubMed ID: 19421811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.